BRPI0415787A - método para determinar se uma substáncia é ligante - Google Patents

método para determinar se uma substáncia é ligante

Info

Publication number
BRPI0415787A
BRPI0415787A BRPI0415787-7A BRPI0415787A BRPI0415787A BR PI0415787 A BRPI0415787 A BR PI0415787A BR PI0415787 A BRPI0415787 A BR PI0415787A BR PI0415787 A BRPI0415787 A BR PI0415787A
Authority
BR
Brazil
Prior art keywords
chimeras
enabling
functional assays
genes
ras
Prior art date
Application number
BRPI0415787-7A
Other languages
English (en)
Inventor
Ethan S Burstein
Fabrice Piu
Jian-Nong Ma
Jacques Thomas Weissman
David M Weiner
Audra L Scully
Norman Nash
Tracy Spalding
Erika Currier
Original Assignee
Acadia Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acadia Pharm Inc filed Critical Acadia Pharm Inc
Publication of BRPI0415787A publication Critical patent/BRPI0415787A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Reproductive Health (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"MéTODO PARA DETERMINAR SE UMA SUBSTáNCIA é LIGANTE". São descritos no presente métodos para permitir ou aprimorar os testes funcionais de receptores acoplados a proteína G por meio do uso da coexpressão de genes auxiliares. Em alguns casos, quimeras que ligam o domínio regulador da proteína rap1B à região efetora do oncogene ras são utilizadas em conjunto com testes funcionais existentes para proliferação celular. Além disso, a sobreexpressão de outros genes pode aumentar ainda mais as propriedades capacitadoras de quimeras ras/rap.
BRPI0415787-7A 2003-11-03 2004-11-02 método para determinar se uma substáncia é ligante BRPI0415787A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51714303P 2003-11-03 2003-11-03
PCT/US2004/036595 WO2005042574A1 (en) 2003-11-03 2004-11-02 High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein

Publications (1)

Publication Number Publication Date
BRPI0415787A true BRPI0415787A (pt) 2006-12-26

Family

ID=34549593

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415787-7A BRPI0415787A (pt) 2003-11-03 2004-11-02 método para determinar se uma substáncia é ligante

Country Status (15)

Country Link
US (2) US20050123964A1 (pt)
EP (1) EP1692165B1 (pt)
JP (1) JP2007536904A (pt)
KR (1) KR20060135644A (pt)
CN (1) CN1875033A (pt)
AT (1) ATE420107T1 (pt)
AU (1) AU2004285964A1 (pt)
BR (1) BRPI0415787A (pt)
CA (1) CA2543451A1 (pt)
DE (1) DE602004018976D1 (pt)
IL (1) IL175332A0 (pt)
NZ (1) NZ546580A (pt)
RU (1) RU2006119434A (pt)
WO (1) WO2005042574A1 (pt)
ZA (1) ZA200603366B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101104088B1 (ko) * 2003-05-14 2012-01-12 에보닉 데구사 게엠베하 표면 개질된 침강 실리카
US20060134670A1 (en) * 2004-11-19 2006-06-22 Fabrice Piu Enabling tools to identify ligands for hormone nuclear receptors
TWI443337B (zh) * 2008-10-10 2014-07-01 Ct Hospitalier Universitaire Sainte Justine 用於脊柱側彎之分類及診斷的方法
US9658208B2 (en) 2011-12-22 2017-05-23 Fred Hutchinson Cancer Research Center Methods and G proteins for screening and identifying ligands of G protein-coupled receptors

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196524A (en) * 1989-01-06 1993-03-23 Eli Lilly And Company Fusion reporter gene for bacterial luciferase
US5661024A (en) * 1989-10-31 1997-08-26 Synaptic Pharmaceutical Corporation DNA encoding a human serotonic (5-HT2) receptor and uses thereof
US5219737A (en) * 1990-03-27 1993-06-15 Kikkoman Corporation Mutant luciferase of a firefly, mutant luciferase genes, recombinant dnas containing the genes and a method of producing mutant luciferase
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5229285A (en) * 1991-06-27 1993-07-20 Kikkoman Corporation Thermostable luciferase of firefly, thermostable luciferase gene of firefly, novel recombinant dna, and process for the preparation of thermostable luciferase of firefly
IL110298A (en) * 1993-07-13 1999-04-11 Brann Mark Robert Identification of ligands by selective amplification of cells transfected with receptors
JP3466765B2 (ja) * 1994-07-27 2003-11-17 キッコーマン株式会社 ビオチン化ホタルルシフェラーゼ、ビオチン化ホタルルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ、ビオチン化ホタルルシフェラーゼの製造法及び生物発光分析法
US5670356A (en) * 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
US8669074B2 (en) * 1996-01-31 2014-03-11 The Regents Of The University Of California Chimeric phosphorylation indicator
US6004808A (en) * 1996-06-21 1999-12-21 Aurora Biosciences Corporation Promiscuous G-protein compositions and their use
US6107324A (en) * 1998-04-14 2000-08-22 Arena Pharmaceuticals Inc. 5-HT2A receptor inverse agonists
US6358698B1 (en) * 1998-10-07 2002-03-19 Acadia Pharmacueticals Inc. Methods of identifying inverse agonists of the serotonin 2A receptor
DE19860834C1 (de) * 1998-12-30 2000-08-24 Albrecht E Sippel Methode zur zellulären High-Throughput-Detektion von nukleären Rezeptor-Liganden-Interaktionen
US6462178B1 (en) * 1999-11-17 2002-10-08 Yong Hou Wong G protein
WO2001046694A2 (en) * 1999-12-22 2001-06-28 Biosignal Packard Inc. A bioluminescence resonance energy transfer (bret) fusion molecule and method of use
WO2002020749A2 (en) * 2000-09-07 2002-03-14 Owman Christer S O Chimeric reporter system for cell surface receptor-ligand binding
DE10226674B4 (de) * 2002-06-12 2006-01-05 Schering Ag Verfahren zur Testung des hormonellen Effekts von Substanzen
EP1455190B1 (de) * 2003-03-04 2006-10-25 Schering Aktiengesellschaft Verfahren zur Bestimmung des hormonellen Effekts von Substanzen mittels der Interaktion zwischen dem Androgenrezeptor und Ewing Sarkoma Protein.
JP2005000132A (ja) * 2003-06-13 2005-01-06 Hitachi Ltd Ｇα蛋白質共発現によるＧＰＣＲ計測方法

Also Published As

Publication number Publication date
KR20060135644A (ko) 2006-12-29
CA2543451A1 (en) 2005-05-12
EP1692165A1 (en) 2006-08-23
DE602004018976D1 (de) 2009-02-26
RU2006119434A (ru) 2007-12-20
CN1875033A (zh) 2006-12-06
WO2005042574A1 (en) 2005-05-12
NZ546580A (en) 2009-06-26
ATE420107T1 (de) 2009-01-15
US20080280303A1 (en) 2008-11-13
AU2004285964A1 (en) 2005-05-12
ZA200603366B (en) 2008-03-26
US20050123964A1 (en) 2005-06-09
JP2007536904A (ja) 2007-12-20
EP1692165B1 (en) 2009-01-07
IL175332A0 (en) 2006-09-05

Similar Documents

Publication Publication Date Title
PH12012502193A1 (en) Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
AR069681A1 (es) Moleculas de union al receptor ox40 humano
BRPI0515264A (pt) construtores multiméricos
BRPI0919473A2 (pt) Agentes de ligação frizzled e usos dos mesmos
GEP20094629B (en) Nogo receptor binding protein
BRPI0920749A8 (pt) Proteínas de ligação de antagonista multialvo cd86
CY1111629T1 (el) Ανθρωπινα αντισωματα ειδικα για kdr και χρησεις αυτων
NO20064866L (no) IRTA-5 antistoffer og deres anvendelse
HRP20190312T1 (hr) Vežući proteini, uključujući protutijela, derivate protutijela i fragmente protutijela, koji se specifično vežu na cd154 i njihova upotreba
NO20080766L (no) IL-6-bindendende proteiner
BRPI0514435A (pt) isolamento seqüêncial de proteìnas e esquemas de purificação através de cromatografia por afinidade
EA200701853A1 (ru) Производные циклопентапиридина и тетрагидрохинолина
NZ605928A (en) Chimeric il-1 receptor type i agonists and antagonists
NO20083406L (no) FGF-reseptorer for dimere forbindelser
ATE427927T1 (de) Phenylacetylenderivate mit affinitat zum mglur5- rezeptor
DE602007012836D1 (de) Cd86- und cd80-rezeptorkonkurrenztests
WO2005028497A3 (en) Receptor binding peptides derived from the sars s protein
BRPI0415787A (pt) método para determinar se uma substáncia é ligante
NZ603942A (en) Vitronectin:keratinocyte growth factor chimeras
ATE542915T1 (de) Cst-ii-modifzierungen für erhöhte proteinexpression
MX2009013167A (es) Uso del factor de crecimiento de fibroblastos 7 (fgf7) y del receptor fgfr2b como biomarcadores.
NO20031033D0 (no) Reseptor i EDb-fibronectindomene
BRPI0514074A (pt) aperfeiçoamentos em composições em bloco para lavatório
BRPI0510561A (pt) epìtopos que induzem morte de célula t
ATE458727T1 (de) Zur modulation des 5-ht6-rezeptors, des 5-ht2a- rezeptors oder beider rezeptoren geeignete arylsulfonylbenzodioxane

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]